You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 9, September 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge: Challenges in Medical and Surgical Therapeutics
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology, Other
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic

Severe Hidradenitis Suppurativa Treated With Adalimumab

Danielle K. Moul, MD; Neil J. Korman, MD, PhD
University Hospitals of Cleveland (Drs Moul and Korman) and Case Western Reserve University (Dr Korman), Cleveland, Ohio

Arch Dermatol. 2006;142:1110-1112.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF A CASE

A 67-year-old white man with a 20-year history of hidradenitis suppurativa (HS) presented for treatment of painful purulent draining sinuses, cysts, and nodules involving his ears, axillae, buttocks, and groin. His medical history was notable for inflammatory bowel disease, which had been treated with a total colectomy in 1971. Prior treatments for his HS included multiple courses of oral antibiotics, surgical resection of the buttocks and axillae, and radiation therapy to his left ear in an attempt to improve the swelling and anatomical disfigurement that were impairing his auditory function. Cultures from his left ear were positive for Escherichia coli. At the time of referral, he was being treated with augmentin (875 mg twice a day) for his HS and associated left otitis externa, otitis media, and mastoiditis. This therapy yielded mild improvement, but the patient continued to have significant . . . [Full Text of this Article]

THERAPEUTIC CHALLENGE

SOLUTION

COMMENT

AUTHOR INFORMATION



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Combination Immunosuppressive Therapies: The Promise and the Peril
Robinson et al.
Arch Dermatol 2007;143:1053-1057.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.